International Journal of Radiation Oncology * Biology * Physics
Volume 74, Issue 1 , Pages 15-20 , 1 May 2009

Mucosal Malignant Melanoma of the Head and Neck Treated by Carbon Ion Radiotherapy

  • Takeshi Yanagi, M.D., Ph.D.

      Affiliations

    • National Institute of Radiological Sciences, Research Center Hospital for Charged Particle Therapy, Chiba, Japan
    • Corresponding Author InformationReprint requests to: Takeshi Yanagi, M.D., Ph.D., Department of Radiation Medicine, Research Center of Charged Particle, National Institute of Radiological Sciences, Anagawa 4-9-1, Inage-ku, Chiba City, Chiba Prefecture 263-8555, Japan. Tel: (+81) 43-206-3306; Fax: (+81) 43-256-6506
    • ,
  • Jun-etsu Mizoe, M.D., Ph.D.

      Affiliations

    • National Institute of Radiological Sciences, Research Center Hospital for Charged Particle Therapy, Chiba, Japan
    • ,
  • Azusa Hasegawa, D.D.S., Ph.D.

      Affiliations

    • National Institute of Radiological Sciences, Research Center Hospital for Charged Particle Therapy, Chiba, Japan
    • ,
  • Ryo Takagi, D.D.S., Ph.D.

      Affiliations

    • National Institute of Radiological Sciences, Research Center Hospital for Charged Particle Therapy, Chiba, Japan
    • ,
  • Hiroki Bessho, D.D.S., Ph.D.

      Affiliations

    • National Institute of Radiological Sciences, Research Center Hospital for Charged Particle Therapy, Chiba, Japan
    • ,
  • Takeshi Onda, D.D.S., Ph.D.

      Affiliations

    • National Institute of Radiological Sciences, Research Center Hospital for Charged Particle Therapy, Chiba, Japan
    • ,
  • Tadashi Kamada, M.D., Ph.D.

      Affiliations

    • National Institute of Radiological Sciences, Research Center Hospital for Charged Particle Therapy, Chiba, Japan
    • ,
  • Yoshitaka Okamoto, M.D., Ph.D.

      Affiliations

    • Division of Otorhinolaryngology, Graduate School of Medicine and School of Medicine, Chiba University, Chiba, Japan
    • ,
  • Hirohiko Tsujii, M.D., Ph.D.

      Affiliations

    • National Institute of Radiological Sciences, Research Center Hospital for Charged Particle Therapy, Chiba, Japan

Received 31 March 2008 ,Revised 10 July 2008 ,Accepted 24 July 2008.

References 

  1. Takahashi M, Kiyodera M. Malignant tumor. In:  Kawamura T editors. Gendai Hihukagaku Taikei 11. Tokyo: Nakayama shoten; 1982;p. 66–87
  2. Omura K, Takemiya S, Shimada F, et al. Malignant melanoma of the head and neck—collective review from six cancer hospitals. Gan No Rinsho. 1986;32:1511–1518
  3. McLaughlin CC, Wu X-C, Jemal A, et al. Incidence of noncutaneous melanomas in the U.S. Cancer. 2005;103:1000–1007
  4. Chang AE, Karnell LH, Menck HR. The National Cancer Data Base report on cutaneous and noncutaneous melanoma: A summary of 84,836 cases from the past decade. The American College of Surgeons Commission on Cancer and the American Cancer Society. Cancer. 1998;83:1664–1678
  5. Ohsumi T, Kiyodera M. Statistical study on malignant melanoma in Japan. Rinsho derma. 1977;19:115–125
  6. Japan Society of Head and Neck Cancer: Cancer Registry Committee. Report of Head and Neck Cancer Registry of Japan: Clinical statistics of registered patients, 2002. Head Neck Cancer. 2006;32(Suppl.):3
  7. Owens JM, Roberts DB, Myers JN. The role of postoperative adjuvant radiation therapy in the treatment of mucosal melanomas of the head and neck region. Arch Otolaryngol Head Neck Surg. 2003;129:864–868
  8. Patel SG, Prasad ML, Escrig M, et al. Primary mucosal malignant melanoma of the head and neck. Head Neck. 2002;24:247–257
  9. Manolidis S, Donald P. Malignant mucosal melanoma of the head and neck: Review of the literature and report of 14 patients. Cancer. 1997;80:1373–1386
  10. Conley J, Hamaker RC. Melanoma of the head and neck. Arch Otolaryngol. 1974;99:315–319
  11. Lee SP, Shimizu KT, Tran LM, et al. Mucosal melanoma of the head and neck: The impact of local control on survival. Laryngoscope. 1994;104:121–129
  12. Lund VJ, Haward DJ, Harding L, et al. Management options and survival in malignant melanoma of the sinonasal mucosa. Laryngoscope. 1999;109:208–211
  13. Stern SJ, Guillamondegui OM. Mucosal melanoma of the head and neck. Head Neck. 1991;13:22–27
  14. Moore ES, Martin H. Melanoma of the upper respiratory tract and oral cavity. Cancer. 1955;8:1167–1176
  15. Rode I. Clinical and radiobiological properties of melanoblastoma. Budapest: Akademiai Kiado; 1968;
  16. Trotti A, Peters LJ. Role of radiotherapy in the primary management of mucosal melanoma of the head and neck. Semin Surg Oncol. 1993;9:246–250
  17. Wada H, Nemoto K, Ogawa Y, et al. A multi-institutional retrospective analysis of external radiotherapy for mucosal melanoma of the head and neck in northern Japan. Int J Radiat Oncol Biol Phys. 2004;59:495–500
  18. Tsujii H, Morita S, Miyamoto T, et al. Preliminary results of phase I/II carbon ion therapy at National Institute of Radiological Sciences. J Brachyther Int. 1997;13:1–8
  19. Tsujii H, Miyamoto T, Mizoe J, et al. Experience of carbon ion radiotherapy at NIRS. In:  Kogelnik HD,  Lukas P, Sedlmayer  editor. Progress in radio-oncology. VII ed. Salzburg: Monduzzi Editore; 2002;p. 393–405
  20. Mizoe J, Tsujii H, Kamada T, et al. Dose escalation study of carbon ion radiotherapy for locally advanced head-and-neck cancer. Int J Radiat Oncol Biol Phys. 2004;60:358–364
  21. Raju MR. Heavy particle radiotherapy. New York: Academic Press; 1980;
  22. Prelec K. Ions and ion accelerators for cancer treatment. FIZIKA B. 1997;6:177–208
  23. Endo M, Koyama-Ito H, Minohara S, et al. HIPLAN: A heavy ion treatment planning system at HIMAC. J Jpn Soc Ther Radiol Oncol. 1996;8:231–238
  24. Kanai T, Endo M, Minohara S, et al. Biophysical characteristics of HIMAC clinical irradiation system for heavy-ion radiation therapy. Int J Radiat Oncol Biol Phys. 1999;44:201–210
  25. Cox JD, Stetz BS, Pajak TF. Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC). Int J Radiat Oncol Biol Phys. 1995;31:1341–1346
  26. Harwood AR, Cummings BJ. Radiotherapy for mucosal melanomas. Int J Radiat Oncol Biol Phys. 1982;8:1121–1126
  27. Overgaard J, Overgaard M, Hansen PV, et al. Some factors of importance in the radiation treatment of malignant melanoma. Radiother Oncol. 1986;5:183–192
  28. Blake PR, Catterall M, Errington RD. Treatment of malignant melanoma by fast neutrons. Br J Surg. 1985;72:517–519
  29. Gilligan D, Slevin NJ. Radical radiotherapy for 28 cases of mucosal melanoma in the nasal cavity and sinuses. Br J Radiol. 1991;64:1147–1150
  30. Blakely EA. Cell inactivation by heavy charged particles. Radiat Environ Biophys. 1992;31:181–196
  31. Smith IE, Courtenay VD, Mills J, et al. In vitro radiation response of cells from four human tumors propagated in immune-suppressed mice. Cancer Res. 1978;38:390–392
  32. Koike S, Ando K, Uzawa A, et al. Significance of fractionated irradiation for the biological therapeutic gain of carbon ions. Radiat Prot Dosimetry. 2002;99:405–408
  33. Kraft G. Tumor therapy with heavy charged particles. Prog Part Nucl Phys. 2000;45:S473–S544
  34. Denekamp J, Waites T, Fowler JF. Predicting realistic RBE values for clinically relevant radiotherapy schedules. Int J Radiat Biol. 1997;71:681–694
  35. Chen GTY, Castro JR, Quinvey JM. Heavy charged particle radiotherapy. Ann Rev Biophys Bioeng. 1981;10:499–529
  36. Thompson LD, Wieneke JA, Miettinen M. Sinonasal tract and nasopharyngeal melanoma. Am J Surg Pathol. 2003;27:594–611

 Conflict of interest: none.

PII: S0360-3016(08)03314-2

doi: 10.1016/j.ijrobp.2008.07.056

International Journal of Radiation Oncology * Biology * Physics
Volume 74, Issue 1 , Pages 15-20 , 1 May 2009

Article Tools

* Image Usage & Resolution